Vaxart director granted shares and stock options
Vaxart, Inc. director James B. Breitmeyer reported receiving equity compensation in the form of common shares and stock options.
Rhea-AI Filing Summary
Vaxart, Inc. director James B. Breitmeyer reported receiving equity compensation in the form of common shares and stock options. He was granted 78,800 shares of Common Stock upon vesting of restricted stock units, with the underlying award vesting in three equal annual installments starting from the grant date, subject to his continued service on the Board of Directors.
He was also granted a stock option for 157,400 shares of Common Stock at an exercise price of $0.7399 per share, expiring on April 23, 2036. The option vests in three equal annual installments from the grant date, also conditioned on continued Board service. These are compensation-related awards rather than open‑market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 236,200 shares
Grant/Award
2 txns
Insider
BREITMEYER JAMES B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 157,400 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 78,800 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 157,400 contracts (Direct);
Common Stock — 78,800 shares (Direct)
Footnotes (2)
- F1. Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest in equal installments on each of the first three anniversaries of the grant date, subject to the reporting person's continuing service on the Board of Directors (the "Board").
- F2. The shares subject to this option shall vest in equal installments on each of the first three anniversaries of the grant date, subject to the reporting person's continuing service on the Board.
Key Figures
RSU shares granted: 78,800 shares
Option shares granted: 157,400 shares
Option exercise price: $0.7399 per share
+3 more
6 metrics
RSU shares granted
78,800 shares
Common Stock grant upon vesting of restricted stock units
Option shares granted
157,400 shares
Stock Option (right to buy) granted to director
Option exercise price
$0.7399 per share
Conversion or exercise price of stock option grant
Option expiration
April 23, 2036
Expiration date of the stock option grant
Shares held after RSU grant
78,800 shares
Total common shares held following RSU transaction
Options held after grant
157,400 options
Total derivative securities held following option grant
Key Terms
restricted stock units, Stock Option (right to buy), vesting, Board of Directors
4 terms
restricted stock units financial
"Grant of shares upon vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy) financial
"Stock Option (right to buy) with an exercise price of 0.7399."
vesting financial
"The shares underlying the award shall vest in equal installments."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Board of Directors financial
"Subject to the reporting person's continuing service on the Board of Directors."
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Vaxart (VXRT) director James B. Breitmeyer report in this Form 4?
James B. Breitmeyer reported receiving equity compensation from Vaxart, Inc., including common stock and stock options. The filing shows grants tied to his service on the Board of Directors, rather than any open-market buying or selling of VXRT shares.
What stock option grant did Vaxart (VXRT) award to its director, and at what exercise price?
Vaxart awarded the director a stock option covering 157,400 shares of common stock at an exercise price of $0.7399 per share. The option is a compensation grant, not an open-market purchase, and provides the right to buy VXRT shares at that stated price.
What is the vesting schedule for the Vaxart (VXRT) restricted stock units and options?
Both the restricted stock units and the stock option vest in three equal annual installments. Vesting occurs on each of the first three anniversaries of the grant date, provided the reporting person continues serving on Vaxart’s Board of Directors throughout the vesting period.
When do the Vaxart (VXRT) stock options granted to the director expire?
The stock options granted to the director expire on April 23, 2036. Until that expiration date, and subject to vesting and continued Board service, the director may choose to exercise the options to purchase VXRT common shares at $0.7399 per share.
Does this Vaxart (VXRT) Form 4 reflect any open-market buying or selling by the director?
No, the Form 4 shows compensation-related equity grants, not open-market trades. The transactions are coded as awards (Code A), indicating grants of restricted stock units and stock options, rather than discretionary purchases or sales of VXRT shares on the market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
